Prism Eye Institute™ believes that research is an essential part of improving eye care for our patients. It is through research and innovation that we are able to offer our patients the best treatment and care options.
We have a long history of participating in large-scale clinical trials as well as producing high quality independent research publications. Our team of world-class ophthalmologists has a keen interest in advancing clinical science in order to be able to offer their patients the best care possible.
Our research team is comprised of our Director of Research Dr. Mike Yang, Chief Innovation Officer Dr Ike Ahmed, a team of Research Coordinators, and two Research Fellows. You can learn more about our GAASS Research Fellowship at https://ophthalmology.utoronto.ca/research-fellow-glaucoma-and-advanced-anterior-segment-surgery-gaass. With over 50 combined years of research experience, our team supports our doctors in all their research endeavors and ensures that all research carried out at Prism Eye Institute™ is of the highest standards.
Our areas of interest include MIGs (micro-invasive glaucoma surgery), diagnostic and monitoring technology for Glaucoma, advanced technology IOLs (intra-ocular lenses), Health Economics of Glaucoma and Cataract therapies, Retina therapeutics and advanced Corneal Surgeries.
For more information on our on-going research, please contacts us at research@prismeye.ca
2014 Binkhorst Medal recipient, Ike Ahmed, is a world-renowned ophthalmologist in the elds of glaucoma, complex cataract surgery and IOL complications. He coined the term “MIGS” – micro-invasive glaucoma surgery – and with his peers, has opened a new ank in the battle to reduce intraocular pressure, ushering in a new generation of surgical approaches and devices.
Recently, a contingent of our doctors and research personnel attended the American Academy of Ophthalmology meeting, both to present our work and learn about advances in eye care. Here’s an example of research done within our clinics looking at the outcomes of two common glaucoma surgeries performed by our doctors.